Bailard’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-13,922
Closed -$118K – 453
2019
Q4
$118K Sell
13,922
-5,000
-26% -$36.1K 0.01% 524
2019
Q3
$128K Hold
18,922
– – 0.01% 509
2019
Q2
$127K Buy
18,922
+3,200
+20% +$17.4K 0.01% 525
2019
Q1
$99K Sell
15,722
-9,900
-39% -$76.6K 0.01% 527
2018
Q4
$164K Buy
+25,622
New +$155K 0.01% 477

Other funds holding APYX

Bailard's APYX Position: Q1 2020 in Review

Bailard sold out of Apyx Medical (APYX) in Q1 2020, closing a stake of 13,922 shares — an estimated $118K sold.

Bailard first reported a position in APYX in Q4 2018 and held it in 5 quarters. The position peaked at $164K in Q4 2018. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2020.

  • Bailard reported no remaining Apyx Medical position as of Q1 2020 after selling out during the quarter.
  • Bailard sold 13,922 Apyx Medical shares in Q1 2020, an estimated $118K.
  • Bailard first reported a position in Apyx Medical in Q4 2018 and held it in 5 quarters.
  • Bailard's Apyx Medical position peaked at $164K in Q4 2018.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2020.

Based on Bailard's 13F filing for Q1 2020, filed 16 Apr 2020.